We also observed that the promotion of glioma cell survival by IGF2BP3-induced NETosis in a contacted co-culture assay could be blocked by CSF3 neutralizing antibodies and enhanced by CSF3 recombinant protein (Fig. 2q–t). Here, IGF2BP3 is linked to central nervous system cancer.